Skip to content

BIOMOL

Active
Private limited companyfounded 200719 yrs activeRue de Chièvres(V.P) 25, 7322 Bernissart, BelgiumKBO/BCE: BE 0887.780.127
Summary

BIOMOL has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.7m and a net result of €192,030. Equity is growing by ~5.7% per year across the filed fiscal years. Its solvency ranks better than 87% of 31896 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability82▲+5
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €140,000 at 30 days acceptable
Liquidity ample (current ratio 20.66 against 19.14 in 2024; short-term debt: 2.1% and cash: 5.9% of total assets), and 11.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 19 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
88.8%
Return on assets
10.3%
Age of the figures
18 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 22-09-2025, 39 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
39 d early
2024
26 d early
2023
20 d early
2022
32 d early
2021
3 d early
2020
9 d early
2019
70 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 28 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven months
Position in the running window
31-03-2026 close27-09-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 8 March 2007, BIOMOL was incorporated.1 Total assets went from EUR 715,823 in 2019 to EUR 1.9 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€1.7m▲ 11.0%
2024 · €1.5m
Total assets
€1.9m▲ 10.1%
2024 · €1.7m
Net result
€192,030▲ 69.0%
2024 · €113,624
Working capital
€763,265▲ 31.0%
2024 · €582,721
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€76,872▲ 26.7%€63,106▼ 17.9%€72,866▲ 15.5%€65,215▼ 10.5%€214,196▲ 228%
Net result€51,542within the sector's middle half▼ 93.6%€52,148within the sector's middle half▲ 1.2%€88,168above the sector's middle half▲ 69.1%€113,624above the sector's middle half▲ 28.9%€192,030above the sector's middle half▲ 69.0%
Equity€1.3mabove the sector's middle half▲ 4.0%€1.3mabove the sector's middle half▲ 1.0%€1.4mabove the sector's middle half▲ 6.6%€1.5mabove the sector's middle half▲ 4.4%€1.7mabove the sector's middle half▲ 11.0%
Total assets€1.5mabove the sector's middle half▲ 2.4%€1.6mabove the sector's middle half▲ 3.4%€1.6mabove the sector's middle half▲ 3.6%€1.7mabove the sector's middle half▲ 4.2%€1.9mabove the sector's middle half▲ 10.1%
Debt€20,397▼ 44.3%€58,559▲ 187%€27,498▼ 53.0%€32,129▲ 16.8%€38,830▲ 20.9%
Working capital€400,818▼ 64.5%€458,448▲ 14.4%€509,542▲ 11.1%€582,721▲ 14.4%€763,265▲ 31.0%
Solvency87.4%above the sector's middle half▲ 1.4pp85.4%above the sector's middle half▼ 2.0pp87.8%above the sector's middle half▲ 2.4pp88.0%above the sector's middle half▲ 0.2pp88.8%above the sector's middle half▲ 0.7pp
above within below the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2021: €76,872€76,872Net result 2021: €51,542€51,542Operating result 2022: €63,106€63,106Net result 2022: €52,148€52,148Operating result 2023: €72,866€72,866Net result 2023: €88,168€88,168Operating result 2024: €65,215€65,215Net result 2024: €113,624€113,624Operating result 2025: €214,196€214,196Net result 2025: €192,030€192,03020212022202320242025€0€100,000€200,000Operating result 2023: €72,866€72,900Net result 2023: €88,168€88,200Operating result 2024: €65,215€65,200Net result 2024: €113,624€114,000Operating result 2025: €214,196€214,000Net result 2025: €192,030€192,000202320242025
The operating result recovers in 2025; 2025 is 228% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.9m
Fixed assets €1.1m ▼ 1.6%
Current assets €802,094 ▲ 30.5%
Equity and liabilities €1.9m
Equity €1.7m ▲ 11.0%
Provisions €170,846 =
Debt €38,830 ▲ 20.9%
Debt's share of the balance-sheet total rises from 1.9% to 2.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€249,949▲
2024 · €78,769
Cash flow
€227,783▲
2024 · €127,178
Current ratio
20.66▲
2024 · 19.14
Debt to equity
0.02▲
2024 · 0.02
ROE
11.6%▲
2024 · 7.6%
ROA
10.3%▲
2024 · 6.7%
Interest coverage
2077.54▲
2024 · 572.82
Debt ≤ 1 year
€38,830▲
2024 · €32,129
Income taxes
€69,362▲
2024 · €53,398
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.7m€1.9m▲
Fixed assets21/28€1.1m€1.1m▼
Tangible fixed assets22/27€275,720€258,793▼
Land and buildings22€212,350€209,043▼
Plant, machinery and equipment23€864€329▼
Furniture and vehicles24€62,507€49,421▼
Financial fixed assets28€803,371€803,371=
Current assets29/58€614,850€802,094▲
Amounts receivable within one year40/41€19,620€17,615▼
Trade receivables40€17,717€17,615▼
Other amounts receivable41€1,903-
Current investments50/53€388,611€670,101▲
Cash at bank and in hand54/58€205,803€110,402▼
Deferred charges and accrued income490/1€817€3,976▲
Equity and liabilities
Total equity and liabilities10/49€1.7m€1.9m▲
Equity10/15€1.5m€1.7m▲
Contributions10/11€12,400€12,400=
Reserves13€1.5m€1.6m▲
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Distributable reserves133€1.5m€1.6m▲
Provisions and deferred taxes16€170,846€170,846=
Provisions for liabilities and charges160/5€170,846€170,846=
Pensions and similar obligations160€170,846€170,846=
Amounts payable17/49€32,129€38,830▲
Amounts payable within one year42/48€32,129€38,830▲
Trade debts44€557€455▼
Suppliers440/4€557€455▼
Taxes, remuneration and social security45€21,839€28,598▲
Taxes450/3€21,839€28,598▲
Other amounts payable47/48€9,734€9,776▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,554€35,753▲
Other operating charges640/8€5,214€8,728▲
Gross operating margin9900€83,983€258,677▲
Operating profit (loss)9901€65,215€214,196▲
Financial income75/76B€101,944€47,316▼
Recurring financial income75€86,254€43,778▼
Non-recurring financial income76B€15,690€3,538▼
Financial charges65/66B€138€120▼
Recurring financial charges65€138€120▼
Profit (loss) for the period before taxes9903€167,022€261,392▲
Income taxes67/77€53,398€69,362▲
Profit (loss) for the period9904€113,624€192,030▲
Profit (loss) for the period to be appropriated9905€113,624€192,030▲
Appropriation of the result
Profit (loss) to be appropriated9906€113,624€192,030▲
Transfer from equity791/2€50,458€28,414▼
Transfer to equity691/2€113,624€192,030▲
To other reserves6921€113,624€192,030▲
Profit to be distributed694/7€50,458€28,414▼
Return on contributions (dividend)694€50,458€28,414▼

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A--€930---
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€38,206€39,483€23,929€13,554€35,753▲ 164%
Other operating charges640/8-€6,386€6,442€5,214€8,728▲ 67.4%
Gross operating margin9900€120,862€108,974€103,236€83,983€258,677▲ 208%
Operating profit (loss)9901€76,872€63,106€72,866€65,215€214,196▲ 228%
Financial income75/76B-€13,959€58,080€101,944€47,316▼ 53.6%
Recurring financial income75€0€13,959€56,576€86,254€43,778▼ 49.2%
Non-recurring financial income76B-€13,959€1,504€15,690€3,538▼ 77.5%
Financial charges65/66B-€160€204€138€120▼ 12.5%
Recurring financial charges65€466€160€204€138€120▼ 12.5%
Profit (loss) for the period before taxes9903€76,406€76,905€130,741€167,022€261,392▲ 56.5%
Income taxes67/77€24,864€24,757€42,573€53,398€69,362▲ 29.9%
Profit (loss) for the period9904€51,542€52,148€88,168€113,624€192,030▲ 69.0%
Profit (loss) for the period to be appropriated9905€51,542€52,148€88,168€113,624€192,030▲ 69.0%
Line20212022202320242025Change
Assets
Total assets20/58€1.5m€1.6m€1.6m€1.7m€1.9m▲ 10.1%
Fixed assets21/28€1.1m€1.1m€1.1m€1.1m€1.1m▼ 1.6%
Tangible fixed assets22/27€283,417€248,660€285,734€275,720€258,793▼ 6.1%
Land and buildings22-€247,352€225,116€212,350€209,043▼ 1.6%
Plant, machinery and equipment23-€930€902€864€329▼ 61.9%
Furniture and vehicles24-€378€59,716€62,507€49,421▼ 20.9%
Financial fixed assets28€812,500€803,371€803,371€803,371€803,371=
Current assets29/58€421,214€517,008€537,040€614,850€802,094▲ 30.5%
Amounts receivable within one year40/41€20,947€3,710€6,980€19,620€17,615▼ 10.2%
Trade receivables40-€466€6,050€17,717€17,615▼ 0.6%
Other amounts receivable41-€3,243€930€1,903--
Current investments50/53€323,934€348,685€378,685€388,611€670,101▲ 72.4%
Cash at bank and in hand54/58€57,767€147,084€151,267€205,803€110,402▼ 46.4%
Deferred charges and accrued income490/1-€17,528€107€817€3,976▲ 387%
Equity and liabilities
Total equity and liabilities10/49€1.5m€1.6m€1.6m€1.7m€1.9m▲ 10.1%
Equity10/15€1.3m€1.3m€1.4m€1.5m€1.7m▲ 11.0%
Contributions10/11-€12,400€12,400€12,400€12,400=
Reserves13€1.3m€1.3m€1.4m€1.5m€1.6m▲ 11.1%
Non-distributable reserves130/1-€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311-€1,860€1,860€1,860€1,860=
Distributable reserves133-€1.3m€1.4m€1.5m€1.6m▲ 11.1%
Provisions and deferred taxes16€170,846€170,846€170,846€170,846€170,846=
Provisions for liabilities and charges160/5-€170,846€170,846€170,846€170,846=
Pensions and similar obligations160-€170,846€170,846€170,846€170,846=
Amounts payable17/49€20,397€58,559€27,498€32,129€38,830▲ 20.9%
Amounts payable within one year42/48€20,397€58,559€27,498€32,129€38,830▲ 20.9%
Trade debts44€202€892€1,221€557€455▼ 18.2%
Suppliers440/4-€892€1,221€557€455▼ 18.2%
Taxes, remuneration and social security45-€11,121€22,975€21,839€28,598▲ 31.0%
Taxes450/3-€11,121€22,975€21,839€28,598▲ 31.0%
Other amounts payable47/48-€46,546€3,302€9,734€9,776▲ 0.4%
Line20212022202320242025Change
Profit (loss) for the period9904€51,542€52,148€88,168€113,624€192,030▲ 69.0%
+ Depreciation and write-downs630€38,206€39,483€23,929€13,554€35,753▲ 164%
Operating cash flow (approximation)€89,748€91,631€112,097€127,178€227,783▲ 79.1%
Investment in fixed assets (approximation)-€4,403-€61,003-€3,540-€18,825▼ 432%
Change in cash-€89,317€4,183€54,535-€95,401▼ 275%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2025
22-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2024
05-10
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2023
11-10
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
31-03
Financial Liquidity doublescurrent ratio 19.53
Current ratio from 8.83 to 19.53; short-term debt falls from €58,559 to €27,498.
2022
29-09
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2021
28-10
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2020
22-10
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
31-03
Financial Highest result since 2019net €811,202 ▲2,755%
Net result €811,202, the highest in the series.
31-03
Financial Liquidity times 6current ratio 31.83
Current ratio from 5.76 to 31.83; short-term debt falls from €62,466 to €36,633.
31-03
Financial Equity above €1mEq €1.3m ▲175%
2 profitable years in a row build equity to €1.3m.
2019
22-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2018
13-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2017
28-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2016
29-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bernissart
exact location from the address register On OpenStreetMap
Ground area
4,225 m²
Building footprint
161 m²
Parcel 51522B0014/00G000, Wallonia. Linked by address, not a title deed.
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
51522B0014/00G000 Wallonia 4,225 m² 1 · 161 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-03-2025 list no shareholders, and no other source names one.

Holdings 1

According to the annual accounts to 31-03-2025 of BIOMOL and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 82,642 companies in sector 70200 we hold annual accounts for 52,589. 22,329 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded08-03-2007
Fiscal year end31-03
Activities, NACEBEL 2025
70200Business and other management consultancy
86910Medical imaging and medical laboratories
E-invoicing
Reachable via Peppol
Peppol ID 0208:0887780127
Registered 19-12-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.